Belite Bio, Inc

Contributing Author

Recent Articles by Belite Bio, Inc

Nov-03	Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results BLTE GlobeNewswire
Nov-02	Belite Bio Announces UK's Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant BLTE GlobeNewswire
Oct-29	Belite Bio to Participate in the Deutsche Bank ADR Virtual Investor Conference BLTE GlobeNewswire
Oct-16	Belite Bio to Participate in the 2025 Maxim Growth Summit BLTE GlobeNewswire
Oct-15	Belite Bio Announces China NMPA Agrees to New Drug Application with Priority Review based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant BLTE GlobeNewswire
Sep-12	Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease BLTE GlobeNewswire
Sep-08	Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors BLTE GlobeNewswire
Aug-27	Belite Bio to Participate in Three Upcoming Investor Conferences BLTE GlobeNewswire
Aug-11	Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update BLTE GlobeNewswire
Aug-07	Belite Bio Announces Registered Direct Offering of $15 Million BLTE GlobeNewswire
Aug-06	Belite Bio to Participate in the H.C. Wainwright Annual Ophthalmology Virtual Conference BLTE GlobeNewswire
Aug-04	Belite Bio to Host Webcast on August 11, 2025, to Discuss Second Quarter 2025 Financial Results BLTE GlobeNewswire
Jul-23	Belite Bio to Participate in the BTIG Virtual Biotechnology Conference BLTE GlobeNewswire
Jul-02	Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy BLTE GlobeNewswire
May-21	Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease BLTE GlobeNewswire
May-13	Belite Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update BLTE GlobeNewswire
May-12	Belite Bio to Participate in Four Upcoming Investor Conferences BLTE GlobeNewswire
May-07	Belite Bio to Host Webcast on May 14, 2025, to Discuss First Quarter 2025 Financial Results BLTE GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.